EUVIMEDEUVIMED entdecken
Crossref

Performance of a fast-track pathway for giant cell arteritis in Waikato, Aotearoa New Zealand

Philippa van Dantzig, Douglas White, Jason Kurz, Caroline Ming, Sujatha Kamalaksha, Vicki Quincey

New Zealand Medical Journal · 2024

DOI: 10.26635/6965.6376 ↗

Kurz gefasst

Fachartikel in der Zeitschrift New Zealand Medical Journal, 2024. Verfasst von Philippa van Dantzig und 5 weiteren Autor:innen. Beteiligte Einrichtung: Rheumatology Department, Te Whatu Ora, Waikato Hospital, Hamilton, New Zealand. Hauptthemen laut MEDLINE: Giant Cell Arteritis.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

aims: Giant cell arteritis (GCA) is the most common primary vasculitis in adults over 50 years of age. To facilitate early diagnosis and reduce harms from corticosteroids and temporal artery biopsies, fast-track pathways have been established. We review the benefits of the fast-track pathway set up in Waikato, Aotearoa New Zealand. methods: Patients were collected prospectively as part of the fast-track pathway from 2014 to 2022. Their records were then reviewed retrospectively to collect data on clinical features, investigations and treatment. results: There were 648 individual patients over the study period who had a colour Doppler ultrasound (CDUS) of the temporal arteries. There were 17 true positive CDUS, giving a sensitivity of 10.3% (95% confidence interval [CI] 6.3–15.5%) and specificity of 99.8% (95% CI 99.1–100%). Patients with GCA and a positive scan had significantly fewer steroids than those with GCA and a negative scan (p=0.0037). There were 376 patients discharged after a CDUS who did not have a diagnosis of GCA, resulting in reduced corticosteroid and temporal artery biopsy exposure. conclusions: This is a real-life study that reflects the benefits of fast-track pathways in Aotearoa New Zealand to patients and healthcare systems. It also shows the effect of corticosteroids on positive CDUS, an important consideration when setting up an fast-track pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Giant Cell ArteritisHumansMiddle AgedAdrenal Cortex HormonesBiopsyNew ZealandRetrospective StudiesTemporal Arteries

Substanzen

Adrenal Cortex Hormones

Autor:innen und Institutionen

  • Rheumatology Department, Te Whatu Ora, Waikato Hospital, Hamilton, New Zealand.
  • Rheumatology Department, Te Whatu Ora, Waikato Hospital, Hamilton, New Zealand; Waikato Clinical School, The University of Auckland, Hamilton, New Zealand.
  • University of Waikato, Hamilton, New Zealand.
  • Rheumatology Department, Te Whatu Ora, Waikato Hospital, Hamilton, New Zealand; Faculty of Medical and Health Sciences, The University of Auckland, Auckland, New Zealand.

Zitieren

APA

van Dantzig, P., White, D., Kurz, J., Ming, C., Kamalaksha, S., & Quincey, V. (2024). Performance of a fast-track pathway for giant cell arteritis in Waikato, Aotearoa New Zealand. New Zealand Medical Journal. https://doi.org/10.26635/6965.6376

Vancouver

van Dantzig P, White D, Kurz J, Ming C, Kamalaksha S, Quincey V. Performance of a fast-track pathway for giant cell arteritis in Waikato, Aotearoa New Zealand. New Zealand Medical Journal. 2024. doi:10.26635/6965.6376

BibTeX
@article{vanDantzig2024,
  author = {van Dantzig, Philippa and White, Douglas and Kurz, Jason and Ming, Caroline and Kamalaksha, Sujatha and Quincey, Vicki},
  title = {Performance of a fast-track pathway for giant cell arteritis in Waikato, Aotearoa New Zealand},
  journal = {New Zealand Medical Journal},
  year = {2024},
  doi = {10.26635/6965.6376}
}
Kostenlos starten →